Evania^® M

Empagliflozin + Metformin Hydrocloride

Description
Evania® M is a combination of empagliflozin, a sodium/glucose co-transporter 2 (SGLT2) inhibitor and metformin hydrochloride, a biguanide, indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus when treatment with both empagliflozin and metformin hydrochloride is appropriate.

Indications
As an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus to reduce the risk of cardiovascular death in adult patients with type 2 diabetes
mellitus and established cardiovascular disease.

Supply
Evania® M Tablet 5mg/500mg: Each box contains 3x10’s tablets in Alu-Alu blister pack.